FZD9 Antibody Cat. No.: 25-681

FZD9 Antibody

Specifications

HOST SPECIES: Rabbit

SPECIES REACTIVITY: Human

Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human FZD9.

TESTED APPLICATIONS: ELISA, WB

FZD9 antibody can be used for detection of FZD9 by ELISA at 1:62500. FZD9 antibody can APPLICATIONS: be used for detection of FZD9 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.

POSITIVE CONTROL: 1) Cat. No. XBL-10123 - Fetal Brain Tissue Lysate

PREDICTED MOLECULAR 64 kDa WEIGHT:

Properties

PURIFICATION: Antibody is purified by peptide affinity chromatography method.

CLONALITY: Polyclonal

CONJUGATE: Unconjugated

PHYSICAL STATE: Liquid

October 8, 2021 1 https://www.prosci-inc.com/fzd9-antibody-25-681.html Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose.

CONCENTRATION: batch dependent

For short periods of storage (days) store at 4˚C. For longer periods of storage, store FZD9 STORAGE CONDITIONS: antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.

Additional Info

OFFICIAL SYMBOL: FZD9

ALTERNATE NAMES: FZD9, FZD3, CD349

ACCESSION NO.: NP_003499

PROTEIN GI NO.: 4503835

GENE ID: 8326

USER NOTE: Optimal dilutions for each application to be determined by the researcher.

Background and References

FZD9 contains 1 FZ () domain and belongs to the G- coupled receptor Fz/Smo family. It is receptor for Wnt . Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target . A second signaling pathway involving PKC and calcium fluxes has been seen for some family members. It may be involved in transduction and intercellular BACKGROUND: transmission of polarity information during tissue morphogenesis and/or in differentiated tissues. Members of the 'frizzled' family encode 7-transmembrane domain proteins that are receptors for Wnt signaling proteins. The FZD9 gene is located within the common deletion region of 7, and heterozygous deletion of the FZD9 gene may contribute to the Williams syndrome phenotype. FZD9 is expressed predominantly in brain, testis, eye, skeletal muscle, and kidney.

REFERENCES: 1) Winn, R.A., (2006) J. Biol. Chem. 281 (37), 26943-26950.

ANTIBODIES FOR RESEARCH USE ONLY.

For additional information, visit ProSci's Terms & Conditions Page.

October 8, 2021 2 https://www.prosci-inc.com/fzd9-antibody-25-681.html